New Medications

Resource Center

Podcasts

NAFLD

Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD

07/15/2020

He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.

07/15/2020

Research Summaries

Conference Coverage

Study Finds Slightly Lower Risk of Richter Transformation for Patients With Chronic Lymphocytic Leukemia in the “Novel Agent Era”

03/13/2024

Anthony Calabro, MA

The study findings potentially challenge the conventional wisdom that the risk of Richter transformation would increase as patients with chronic lymphocytic leukemia live longer with novel treatments. This...

03/13/2024

FDA Alert

FDA Approves Irinotecan Liposome For First-Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma

03/04/2024

Anthony Calabro, MA

The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.

03/04/2024

FDA Alert